TrialOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2013

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years.

M R McClung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.